Literature DB >> 10573532

Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation.

M G Pessoa1, N Bzowej, M Berenguer, Y Phung, M Kim, L Ferrell, H Hassoba, T L Wright.   

Abstract

Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C-infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C-infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow-up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.

Entities:  

Mesh:

Year:  1999        PMID: 10573532     DOI: 10.1002/hep.510300610

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.

Authors:  Takasuke Fukuhara; Kazutoyo Morita; Kazuki Takeishi; Takeo Toshima; Kenji Umeda; Shigeyuki Nagata; Keishi Sugimachi; Toru Ikegami; Tomonobu Gion; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

Review 3.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

4.  Fibrosing cholestatic hepatitis with hepatitis C virus treated by double filtration plasmapheresis and interferon plus ribavirin after liver transplantation.

Authors:  Teruki Miyake; Kojiro Michitaka; Yoshio Tokumoto; Shinya Furukawa; Teruhisa Ueda; Yoshiko Soga; Masanori Abe; Bunzo Matsuura; Taro Nakamura; Taiji Tohyama; Nobuaki Kobayashi; Yoichi Hiasa; Morikazu Onji
Journal:  Clin J Gastroenterol       Date:  2009-01-10

Review 5.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

6.  Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.

Authors:  Shu-Yuan Xiao; Liang Lu; Hanlin L Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 8.  Human liver transplantation as a model to study hepatitis C virus pathogenesis.

Authors:  Michael G Hughes; Hugo R Rosen
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

Review 9.  Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management.

Authors:  Bobby Kakati; Anil Seetharam
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

Review 10.  New insights in recurrent HCV infection after liver transplantation.

Authors:  Shih-Hsien Hsu; Ming-Lun Yeh; Shen-Nien Wang
Journal:  Clin Dev Immunol       Date:  2013-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.